Medicago, GSK Report 71% Efficacy Rate From Plant-Based COVID-19 Vaccine Study

Quebec-based biopharmaceutical firm Medicago and healthcare conglomerate GlaxoSmithKline (NYSE: GSK) announce today the results from its global Phase 3 efficacy study of its COVID-19 vaccine candidate. The data showed an overall efficacy rate of 71% against all variants of SARS-CoV-2, the virus that causes the pandemic disease.

The Canadian firm’s plant-based vaccine candidate is combined with GSK’s pandemic adjuvant. The firm is using a unique technology to produce virus-like particles, designed to mimic the virus structure for the immune system to recognize ahead of the potential infection.

The study, started in March 2021, was conducted with over 24,000 subjects ages 18 years old and above across Canada, the United States, the United Kingdom, Mexico, Argentina, and Brazil. The vaccine was administered in two doses of 3.75 µg, 21 days apart.

The vaccine candidate also showed a 75.3% efficacy rate specifically against the Delta variant and 88.6% against the Gamma variant. The emerging Omicron variant has not been considered yet in the study.

During the study, the firm reported no related serious adverse events while reactions to the vaccine were “generally mild to moderate and transient”, with “symptoms lasting on average only 1 to 3 days.”

The biopharmaceutical firm plans to seek regulatory approval from Health Canada as part of its rolling submission. The phase 3 results are also expected to be released in a peer-reviewed publication.


Information for this briefing was found via the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Is Gold’s Bull Market About to Hit Junior Stocks? | Ken Armstrong – Westhaven Gold

Surge Battery Metals: The Nevada North Lithium PEA

Silver @ $36 & We’re Still 200M Oz Short | Paul Andre Huet – Americas Gold and Silver

Recommended

Goliath Resources Closes Out Funding Round With Total Gross Proceeds Of $27.1 Million

Silver47 Kickstarts 4,000 Metre Drill Campaign At Red Mountain Project

Related News

China Protestors Have Zero Tolerance For China’s Zero COVID Policy

Beijing attempts to walk back on its stringent pandemic measures as uprising has been gaining...

Tuesday, November 29, 2022, 10:23:00 AM

Not Bats, But Raccoons Could’ve Started The COVID-19 Pandemic – Experts

An international team of virus experts announced on Thursday that they had discovered genetic data...

Friday, March 17, 2023, 03:09:00 PM

Datametrex Announces Launch Of Concierge COVID-19 Testing Service

Datametrex AI (TSXV: DM) this morning announced the launch of a unique new service, referred...

Wednesday, January 6, 2021, 08:15:44 AM

Tesla Stops Nearly All Production at Shanghai Factory Amid Parts Shortages

Tesla (NASDAQ: TSLA) has reportedly suspended nearly all production at its Shanghai factory, after running...

Tuesday, May 10, 2022, 05:04:00 PM

IEA Cuts Global Oil Demand Forecast as Renewed Lockdowns Limit Mobility

The International Energy Agency (IEA) has revised its 2021 oil forecast, cutting oil demand by...

Saturday, January 23, 2021, 04:26:00 PM